B3GNT2P1

Across TCGA pan-cancer cohorts, B3GNT2P1 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of B3GNT2P1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where B3GNT2P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types B3GNT2P1 is over-expressed in tumor.

BRCA are the cancer types where B3GNT2P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in B3GNT2P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	All	II,III,IV	+0.003	.046	4	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

B3GNT2P1–BRCA

Open the BRCA breakdown →